Logo image of CPRX

CATALYST PHARMACEUTICALS INC (CPRX) Stock Analyst Ratings

NASDAQ:CPRX - Nasdaq - US14888U1016 - Common Stock

22.92  +0.14 (+0.61%)

After market: 23.1975 +0.28 (+1.21%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to CPRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 32.9. This target is 43.52% above the current price.
CPRX was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CPRX.
In the previous month the buy percentage consensus was at a similar level.
CPRX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
CPRX Historical Analyst RatingsCPRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -97 -88 -79 -70 -61 -52 -43 -34 -25 -16 -7 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 22.9228.2831.6232.9039.90 - 23.39% 37.96% 43.52% 74.08%
CPRX Current Analyst RatingCPRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-01-10 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-09 B of A Securities Reiterate Buy -> Buy
2024-11-18 Stephens & Co. Initiate Overweight
2024-11-11 Truist Securities Maintains Buy -> Buy
2024-11-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-12 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-09 Truist Securities Maintains Buy -> Buy
2024-08-09 Citigroup Maintains Buy -> Buy
2024-06-06 Oppenheimer Reiterate Outperform -> Outperform
2024-06-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-10 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-27 Oppenheimer Reiterate Outperform -> Outperform
2024-03-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-14 Citigroup Initiate Buy
2024-03-07 B of A Securities Initiate Buy
2024-03-01 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-03-01 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-21 Oppenheimer Initiate Outperform
2023-08-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-11 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-08-11 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-21 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-21 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-06-21 Truist Securities Maintains Buy
2023-06-20 Truist Securities Maintains Buy
2023-05-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-20 HC Wainwright & Co. Reiterate Buy
2023-01-19 Truist Securities Maintains Buy
2022-12-21 Truist Securities Maintains Buy